Estimated Research and Development Investment Needed to Bring a New Medicine to Market, 2009-2018
Study of 355 new drugs and biologics approved by the FDA over the 10 year period found that the median research and development investment to bring a new drug to market was $985.3 million, ranging from $765M for neurological agents to $2771 million for antineoplastics.
Source:
Journal of the American Medical Association
Resource links:
Affording Medicines for Today’s Patients and Sustaining Innovation for Tomorrow
SPS commentary:
Related commentaries, from the US perspective, discuss the implications of increasing drug prices and how this relates to research and development costs.